Company Number: 13603036

Analysis Date: 2025-07-29 17:27 UTC

1. Industry Classification
   MEDIFAST DELIVERY LIMITED operates under SIC code 47730, classified as a "Dispensing chemist in specialised stores." This sector is part of the broader retail trade industry (SIC 47), focusing specifically on the retail distribution of pharmaceutical and healthcare products through specialized outlets. Key industry characteristics include regulatory compliance with healthcare standards, reliance on prescription and over-the-counter medicine sales, and increasing competition from both traditional pharmacies and online platforms.

2. Relative Performance
   As a micro-entity company incorporated in 2021, MEDIFAST DELIVERY LIMITED is a very small player within the dispensing chemist sector. Its financials show net assets of approximately £56,000 as of September 2024, with modest fixed assets (~£15,000) and current liabilities exceeding current assets, indicating a working capital deficit (net current liabilities of around £70,000). The company has grown slightly in current assets but also increased liabilities, suggesting tight liquidity. The average employee count of 5 is consistent with a micro or small retail operation. Compared to typical industry benchmarks, dispensing chemists often operate with higher turnovers and larger asset bases, reflecting inventory levels and point-of-sale infrastructure. Hence, MEDIFAST DELIVERY LIMITED is operating below average scale and financial robustness typical of established pharmacy retailers.

3. Sector Trends Impact
   The UK dispensing chemist sector is undergoing significant transformation driven by digitalization, increasing online pharmaceutical sales, and changes in NHS funding and prescription reimbursement policies. There is growing consumer preference for integrated healthcare services and convenience, with large chains and online-only competitors consolidating market share. Additionally, regulatory compliance and supply chain resilience remain critical, especially post-pandemic. For a micro-entity like MEDIFAST DELIVERY LIMITED, these trends pose both challenges and opportunities: challenges in competing with larger, more capitalized players, but opportunities to specialize in niche products or personalized services that differentiate from mass-market chains.

4. Competitive Positioning
   MEDIFAST DELIVERY LIMITED appears to be a niche or follower-level player within the dispensing chemist sector. Its small scale and modest asset base limit its competitive reach compared to large chain pharmacies (e.g., Boots, Lloyds) or online platforms (e.g., Pharmacy2U). Strengths may include agility, localized customer relationships, and potential specialization. However, weaknesses include limited financial resources, working capital constraints, and potentially limited purchasing power and marketing reach. Without significant expansion or differentiation, sustaining growth in this competitive environment may be difficult.